We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.4B
2
NVDA icon
NVIDIA
NVDA
+$388M
3
MSFT icon
Microsoft
MSFT
+$182M
4
AMZN icon
Amazon
AMZN
+$177M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$163M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$213M
2
AVGO icon
Broadcom
AVGO
+$103M
3
UNP icon
Union Pacific
UNP
+$100M
4
ETHA
iShares Ethereum Trust ETF
ETHA
+$89.9M
5
MRVL icon
Marvell Technology
MRVL
+$89.4M

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRU icon
1276
Prudential Financial
PRU
$41.8B
$666K ﹤0.01%
5,904
-109,339
-95% -$11.7M
AXIA
1277
AXIA Energia
AXIA
$23.3B
$664K ﹤0.01%
72,460
-66,710
-48% -$577K
HDB icon
1278
HDFC Bank
HDB
$121B
$661K ﹤0.01%
+18,099
New +$651K
GRAL
1279
GRAIL Inc
GRAL
$3.1B
$661K ﹤0.01%
7,719
-302
-4% -$26.1K
SOBO
1280
South Bow Corp
SOBO
$7.43B
$659K ﹤0.01%
23,975
-14,459
-38% -$393K
AARD
1281
Aardvark Therapeutics
AARD
$173M
$658K ﹤0.01%
50,131
-203,621
-80% -$2.54M
TALO icon
1282
Talos Energy
TALO
$2.4B
$658K ﹤0.01%
+59,686
New +$625K
TDUP icon
1283
ThredUp
TDUP
$422M
$658K ﹤0.01%
102,928
+72,014
+233% +$583K
XRAY icon
1284
Dentsply Sirona
XRAY
$2.43B
$651K ﹤0.01%
56,973
-219,464
-79% -$2.58M
ATAT icon
1285
Atour Lifestyle Holdings
ATAT
$4.8B
$647K ﹤0.01%
+16,426
New +$644K
EFC
1286
Ellington Financial
EFC
$1.71B
$646K ﹤0.01%
+47,557
New +$647K
BOKF icon
1287
BOK Financial
BOKF
$8.74B
$644K ﹤0.01%
+5,438
New +$610K
TRS icon
1288
TriMas Corp
TRS
$1.44B
$644K ﹤0.01%
18,162
-21,448
-54% -$749K
VET icon
1289
Vermilion Energy
VET
$1.66B
$643K ﹤0.01%
+77,102
New +$636K
MRNA icon
1290
Moderna
MRNA
$23.6B
$642K ﹤0.01%
+21,777
New +$592K
DOLE icon
1291
Dole
DOLE
$1.32B
$642K ﹤0.01%
42,825
-2,342
-5% -$32.6K
CROX icon
1292
CALL
Crocs
CROX
$6.55B
$641K ﹤0.01%
+7,500
New +$627K
CROX icon
1293
PUT
Crocs
CROX
$6.55B
$641K ﹤0.01%
+7,500
New +$627K
GAP
1294
CALL
The Gap Inc
GAP
$7.37B
$640K ﹤0.01%
25,000
– –
CASH icon
1295
Pathward Financial
CASH
$1.8B
$639K ﹤0.01%
8,994
-14,762
-62% -$1.06M
TGTX icon
1296
TG Therapeutics
TGTX
$7.62B
$638K ﹤0.01%
21,390
+3,986
+23% +$130K
GENI icon
1297
Genius Sports
GENI
$2.11B
$637K ﹤0.01%
57,790
-47,135
-45% -$514K
SMRT icon
1298
SmartRent
SMRT
$272M
$637K ﹤0.01%
315,121
+44,383
+16% +$72.7K
KGC icon
1299
Kinross Gold
KGC
$32.8B
$636K ﹤0.01%
22,569
+473
+2% +$12.3K
EGBN icon
1300
Eagle Bancorp
EGBN
$845M
$635K ﹤0.01%
+29,653
New +$571K
50 51
52
53 54

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.